Malley Thomas bought KNSA
August 13, 2025 · Form 4 insider transaction
Malley Thomas bought 30,000 shares of Kiniksa Pharmaceuticals International, plc at $9.88 per share, a transaction worth $296.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$9.88
Total value
$296.4K
InsiderMalley Thomas
RoleDirector
SecurityClass A Ordinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 13, 2025
Filing dateAugust 14, 2025
Shares owned after62,675
OwnershipDirect
10b5-1 planNo
AmendedNo